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Getting lamin B1 processed and organized
 
amins are the building blocks of the nuclear lamina, 
a complex polymer attached to the nuclear envelope that 
is thought to be important for nuclear stability, chromatin 
organization, and gene expression. On page 1223, Maske 
et al. identify the protease responsible for processing lamin 
B1, demonstrate the existence of a nuclear receptor specific 
for carboxymethylated lamin B1, and show that posttrans-
lational processing may control the localization of this lamin 
into subdomains within the nuclear envelope.
L
 
After being farnesylated, the COOH-terminal CAAX 
domain of lamin 
B1 is cleaved by 
an endoprotease, 
and the new 
COOH terminus 
of the protein is 
then methylated 
by the enzyme 
Icmt. Using a 
monoclonal anti-
body that distin-
guishes proteolyzed 
from unproteolyzed 
lamin B1, the 
authors determined 
that proteolysis  Lamin B1 (yellow) is present in subdomains.
 
How to block botox
 
rom both chemical weapons inspectors 
and plastic surgeons, botulinum toxins 
are the focus of intense interest. But how 
do these incredibly toxic proteins get 
into cells? On page 1293, Dong et al. 
demonstrate that botulinum neurotoxin B 
(BoNT/B) uses the vesicle proteins synapto-
tagmin I and synaptotagmin II as cellular 
receptors, and that a fragment of synapto-
tagmin II can inhibit the toxin’s effects in 
animals.
Of the seven known neurotoxins ex-
pressed by 
 
Clostridium botulinum
 
, BoNT/
A, B, and E are the most common causes 
of botulism in humans and the major 
choices for both bioterrorist and pharma-
ceutical uses. In previous work, researchers 
identified several cellular proteins that 
can bind to these toxins, but there were 
conflicting data about which, if any, of 
the candidate receptors actually mediate 
F
 
specifically requires the CAAX endoprotease Rce1. Separate 
pools of farnesylated but unproteolyzed and proteolyzed 
but unmethylated lamin B1 appear in the nucleus, but 
retention of the protein’s COOH terminus in the nuclear 
envelope requires carboxymethylation, indicating that 
a nuclear receptor specifically recognizes the fully 
processed form of the protein. When farnesylation is 
inhibited, the residual mature form occupies defined 
subdomains of the nuclear lamina, and the authors have 
preliminary evidence that these subdomains are also present 
in untreated cells.
The results suggest that methylation of lamin B1 is a novel 
mechanism controlling the higher order organization of the 
nucleus. Lamin B1 interacts with chromatin, so the protein’s 
controlled localization to subdomains of the lamina might 
organize interacting chromatin into similar domains. The 
authors are now trying to identify the nuclear receptor for 
carboxymethylated lamin B1.
Since the well-known oncogene 
 
ras
 
 also requires processing 
of its CAAX domain, CAAX endoproteases, including Rce1, 
are popular targets for a new generation of experimental 
anticancer drugs. It was initially thought that CAAX processing 
was unnecessary in nondividing cells, but the new findings 
show that interfering with lamin B1 processing disrupts the 
integrity of the nuclear envelope, highlighting the potential 
for unforeseen side effects with the new drugs.
 
 
 
 
 
cellular entry. Once inside neurons, the 
toxins act as proteases to block exocytosis, 
ultimately leading to paralysis and death.
Using both loss-of-function and gain-of-
function approaches, Dong et al. show that 
synaptotagmin I or synaptotagmin II can 
act as a receptor to internalize BoNT/B 
into PC-12 cells. Fusion of synaptic vesicles 
with the plasma membrane, and thus display 
of vesicle proteins on the cell surface, 
occurs during excitation. Indeed, BoNT 
internalization is dependent on electrical 
activity in two different cell types. Fragments 
of synaptotagmin II effectively block the 
binding of BoNT/B to cultured cells and 
inhibit the activity of the toxin in mice, 
providing strong evidence that the interac-
tion is biologically relevant.
In the mouse experiments, an injection 
of synaptotagmin II fragments partially 
protected the animals against a subsequent 
challenge with BoNT/B. This is the first 
demonstration that a fragment from a 
bacterial toxin receptor can antagonize 
the toxin in animals. The authors are 
now defining the precise requirements for 
BoNT/B–synaptotagmin II interactions, 
and are also trying to identify the receptors 
for other 
 
Clostridium
 
 neurotoxins. 
 
 
Botulinum toxin (green) gets into cells 
thanks to synaptotagmin I (red).
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Pop goes the 
acrosome
 
lthough most cell biol-
ogists think of molecular 
motors as chemically driven 
machines, some of the 
fastest and most dramatic 
movements in nature may 
actually be powered by 
stored mechanical energy. 
On page 1183, Shin et al. 
present a detailed character-
ization of the forces driving 
acrosome extension in the 
sperm of the horseshoe crab 
 
Limulus polyphemus
 
, and 
A
A coil of actin (red) springs open in front 
of the Limulus sperm nucleus (blue).
 
show that this process relies on mechanical energy stored in a 
molecular spring. Springs also underlie other phenomena such as 
bacteriophage infection.
To penetrate the jelly coat of an egg, 
 
Limulus
 
 sperm extends a bundle 
of actin filaments from a coiled position in the sperm head into a 
sturdy 60-mM-long rod called the acrosomal process. The reaction 
takes only five seconds. The authors calculated the amount of mechanical 
energy theoretically required to drive the movement from the energy 
stored in the structure and expended during extension. Neither ATP 
hydrolysis nor calcium binding provides enough energy during the 
reaction, but the potential mechanical energy in the coiled actin bundle 
is more than sufficient to drive acrosome extension. The data suggest 
that calcium binding triggers, but does not power, a progressive 
mechanical uncoiling reaction, extending the acrosomal process like 
a Jack-in-the-box toy. 
 
 
 
A long version of Short stop
 
he 
 
Drosophila
 
 Short stop (Shot/Kakapo) gene 
encodes several protein isoforms, some of which 
may link integrins to microtubules. In analyzing the 
Shot locus, Röper and Brown (page 1305) found 
something odd: a previously unnoticed exon encoding 
a series of plakin repeats. The only known function 
of plakin repeats though is to interact with cytoplasmic 
intermediate filaments, which flies lack.
Based on a 
biochemical 
analysis, the 
plakin repeats 
are incor-
porated into 
a gigantic iso-
form of Shot 
that is the third-largest protein discovered in flies. 
This isoform includes an actin-binding domain, the 
plakin repeats, a microtubule-binding domain, and 
spectrin repeats, and is found in adherens junctions, 
a localization that seems to be determined by a 
portion of the plakin domain. Reducing the quantity 
of the largest Shot isoform in early embryos weakens 
epithelial intercellular contacts, so it is essential for 
maintaining epithelial integrity.
The authors propose that the giant Shot isoform helps 
link the adherens junction to an associated belt of 
actin filaments and microtubules. This novel inter-
mediate filament-independent activity of plakin repeats 
may be a conserved function of the domain, or it 
could be a distinct adaptation in insects, where a 
lack of intermediate filaments left the plakin domain 
free to evolve a new function.
 
 
 
 
T
Plakin repeats (green) take Shot to 
adherens junctions (red).
 
NgCAM takes a scenic route to the axon
 
o establish and maintain their asym-
metrical structure, neurons must sort 
different proteins to their somatodendritic 
and axonal membranes. Previous work has 
supported three different models to explain 
selective transport to axons: direct transport 
to the axon; selective fusion of vesicles with 
the axon; and transport to the somato-
dendritic membrane followed by trans-
cytosis. A detailed analysis by Wisco et al. 
(page 1317) now identifies evidence that 
the adhesion molecule NgCAM can take 
two of these three paths.
Some recent evidence suggests that 
vesicles containing NgCAM are blocked 
from fusing with the somatodendritic 
membrane in the first place. But in a 
T
 
kinetic analysis, Wisco et al. show that in 
fact NgCAM does transiently appear on 
the somatodendritic membrane, but is 
then endocytosed and sent to the axonal 
membrane by a transcytotic pathway.
The NgCAM protein encodes all of 
the signals necessary to direct it to the 
transcytotic pathway. A mutant NgCAM 
protein lacking the transcytosis signal 
is instead sent directly to the axonal 
membrane from the trans-Golgi network, 
suggesting that two distinct pathways are 
available to NgCAM, but transcytosis 
normally supersedes direct targeting. The 
authors now hope to determine whether 
this circuitous route is unique to NgCAM 
or common to many axonal proteins. 
 
 
NgCAM gets internalized (red) on the way 
to the axon (blue).
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